Skip to main content

Table 2 Effect of methanolic extract of Luffa cylindrica (L.) leaves on Biochemical Parameters in wistar rats

From: Pharmacodynamic findings for the usefulness of Luffa cylindrica (L.) leaves in atherosclerosis therapy with supporting antioxidant potential

Group TC (mg/dl) TG (mg/dl) HDL (mg/dl) VLDL (mg/dl) LDL(mg/dl)
Normal 79.63 ± 2.715 66.05 ± 1.069 38.04 ± 1.960 13.21 ± 0.213 28.38 ± 2.319
Hyperlipidemic (Triton X-100) 149.16 ± 4.467 123.07 ± 5.421 16.45 ± 1.416 24.61 ± 1.084 108.1 ± 16.779
Atorvastatin (10mg/kg) 85.56 ± 6.128** 59.12±7.242*** 40.76±1.404*** 11.82±1.449** 34.65±4.642***
MELCL (100mg/kg) 92.46 ± 6.032** 77.88 ± 8.178** 38.58±1.767*** 15.57±1.759** 37.28±7.254**
MELCL (200mg/kg) 85.48±3.230*** 74.62 ± 8.764** 40.58±1.625*** 14.92±1.635** 31.97±3.475***
  1. Values are expressed as mean ± S.E.M; n=6, *P<0.05, **P<0.01, ***P<0.001 when group hyperlipidemic control compared with normal and group atorvastatin, MELCL(100mg/kg) and MELCL (200mg/kg) were compared with hyperlipidemic control considered for significance, (ANOVA followed by Dunnett’s test)
  2. MELCL Methanolic extract of Luffa cylindrica (L.) leaves, TC Total Cholesterol, TG Triglycerides, LDL Low-Density Lipoproteins, VLDL Very Low-Density Lipoproteins, HDL High-Density Lipoproteins